Innovation
Share your love
Posterior Capsular Opacification | OBN
What Is Post-Capsular Opacification? After a smooth sail through cataract surgery, post capsular opacification (PCO) can appear like a rogue wave, unexpected and potentially disruptive. It’s not an iceberg that sinks the ship, but it’s certainly worth keeping an eye…
OcuCell Partners with Georgia Eye Bank for Funding
OcuCell, a provider of ocular cell therapy, has announced funding from the Georgia Eye Bank. Established in 1961, the Georgia Eye Bank has contributed over 60,000 corneas for transplantation, demonstrating a commitment to enhancing vision and enriching lives through the…
VSY Biotechnology Announces 2023 OSA Winners
VSY Biotechnology GmbH, a global leader in ophthalmic innovation and research, announced the winners of the Ophthalmology Star Awards (OSA) at the Satellite Symposium at the ESCRS 2023 in Vienna. The traditional Ophthalmology Star Awards ceremony celebrates outstanding contributions to…
VSY’s ENOVA: Glistening-Free Hydrophobic IOL
VSY Biotechnology launches Enova, the First 100% Glistening Free Hydrophobic Acrylic IOL that does not Require Pre-hydration and Storage in Saline Solution! VSY Biotechnology announces Enova, the first 100% glistening-free hydrophobic acrylic IOL that requires neither pre-hydration nor storage in…
HOYA Surgical Optics Acquires Mid Labs and Fritz Ruck
HOYA Surgical Optics (“HSO”), the intraocular lens and related products division of HOYA Group, today announced that it has completed the acquisition of medical device companies Mid Labs and Fritz Ruck. Mid Labs is a California-based company focused on the…
Caeregen Therapeutics Secures $1.4M Research Grant
Caeregen Therapeutics announced that it has received a $1.4 million Phase 2 Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) and National Eye Institute (NEI). The grant has been awarded to further the advancement of…
Alkem Laboratories Enters Ophthalmology Field
Alkem Laboratories has made its foray into the field of ophthalmology by introducing a comprehensive range of affordable and high-quality eye care products. This strategic expansion showcases Alkem’s dedication to innovation and commitment to meeting the diverse needs of patients…
Cellusion Secures $21 Million Funding
Cellusion, a Tokyo-based biotech company, announced the successful completion of its Series C Round financing, raising an impressive 2.83 billion yen, equivalent to $21 million. The primary focus of this funding is to accelerate the advancement of Cellusion’s lead program,…
VSY Biotechnology Achieved Strong Growth in Q1 2023
VSY Biotechnology GmbH is moving towards achieving its growth targets with incremental steps. The company’s General Manager, Andreas Kühnel, evaluated the impressive Q1 2023 results of the company in the following statement: “Our net sales in the first quarter of…
New Contact Lens to Prevent DED
A collaborative team from the Terasaki Institute for Biomedical Innovation (TIBI) has developed a contact lens prototype that is specifically designed to prevent contact lens-induced dry eye (CLIDE). The new lens helps treat this condition by enabling tear flow in…